Corticosteroid and tacrolimus treatment in neuromyelitis optica related disorders

Multiple Sclerosis Journal

Volumn 21, Issue 5, 2015, Pages 669-

  Tanaka, Masami ^a   Kinoshita, Masako ^a   Tanaka, Keiko ^b  

^a UTANO NATIONAL HOSPITAL   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; TACROLIMUS; AQUAPORIN 4 ANTIBODY; CORTICOSTEROID; PREDNISOLONE;

CHOLANGITIS; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DRUG SAFETY; HUMAN; LETTER; MYELOOPTIC NEUROPATHY; RELAPSE; TREATMENT DURATION; TREATMENT OUTCOME; ALOPECIA; ANTIBODY DETECTION; CHEMOPROPHYLAXIS; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; DRUG BLOOD LEVEL; DRUG ERUPTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; LEUKOPENIA; MONOTHERAPY; NEUROMYELITIS OPTICA RELATED DISORDER; RETROSPECTIVE STUDY;

EID: 84938484065     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514546793     Document Type: Letter

References (5)

1. Lucey MR1, Abdelmalek MF, Gagliardi R, et al. A comparison of tacrolimus and cyclosporine in liver transplantation: Effects on renal function and cardiovascular risk status. Am J Transplant. 2005 ; 5: 1111-1119
2. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007 ; 6: 805-815
3. Tanaka K, Tani T, Tanaka M, et al. Anti-Aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult Scler. 2007 ; 13: 850-855
4. Tanaka M, Tanaka K, Komori M. Interferon-beta(1b) treatment in neuromyelitis optica. Eur Neurol. 2009 ; 62: 167-170
5. Morita Y, Sasae Y, Sakuta T, et al. Efficacy of low-dose tacrolimus added to methotrexate in patients with rheumatoid arthritis in Japan: A retrospective study. Mod Rheumatol. 2008 ; 18: 379-384